- Home
- PSNYW vs RCKT Comparison
PSNYW vs RCKT Comparison
Compare PSNYW & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- RCKT
- Stock Information
- Founded
- PSNYW 2017
- RCKT 1999
- Country
- PSNYW Sweden
- RCKT United States
- Employees
- PSNYW 2547
- RCKT N/A
- Industry
- PSNYW Auto Manufacturing
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- PSNYW Consumer Discretionary
- RCKT Health Care
- Exchange
- PSNYW Nasdaq
- RCKT Nasdaq
- Market Cap
- PSNYW 625.2M
- RCKT 328.6M
- IPO Year
- PSNYW N/A
- RCKT N/A
- Fundamental
- Price
- PSNYW $0.30
- RCKT $3.28
- Analyst Decision
- PSNYW
- RCKT Buy
- Analyst Count
- PSNYW 0
- RCKT 13
- Target Price
- PSNYW N/A
- RCKT $12.96
- AVG Volume (30 Days)
- PSNYW 43.4K
- RCKT 6.0M
- Earning Date
- PSNYW 03-06-2025
- RCKT 08-07-2025
- Dividend Yield
- PSNYW N/A
- RCKT N/A
- EPS Growth
- PSNYW N/A
- RCKT N/A
- EPS
- PSNYW N/A
- RCKT N/A
- Revenue
- PSNYW $2,034,261,000.00
- RCKT N/A
- Revenue This Year
- PSNYW N/A
- RCKT N/A
- Revenue Next Year
- PSNYW $79.49
- RCKT $108.43
- P/E Ratio
- PSNYW N/A
- RCKT N/A
- Revenue Growth
- PSNYW N/A
- RCKT N/A
- 52 Week Low
- PSNYW $0.09
- RCKT $2.19
- 52 Week High
- PSNYW $0.61
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- PSNYW 56.04
- RCKT 51.17
- Support Level
- PSNYW $0.16
- RCKT $2.88
- Resistance Level
- PSNYW $0.80
- RCKT $3.74
- Average True Range (ATR)
- PSNYW 0.06
- RCKT 0.27
- MACD
- PSNYW 0.02
- RCKT 0.02
- Stochastic Oscillator
- PSNYW 15.62
- RCKT 35.43
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.